Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV002007565 | SCV002234820 | pathogenic | not provided | 2024-03-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1389Glyfs*13) in the TUBGCP6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TUBGCP6 are known to be pathogenic (PMID: 25344692). This variant is present in population databases (rs752869602, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. For these reasons, this variant has been classified as Pathogenic. |
| Daryl Scott Lab, |
RCV005256834 | SCV005911576 | pathogenic | Microcephaly and chorioretinopathy 1 | 2024-04-01 | criteria provided, single submitter | clinical testing | PVS1, PM2, PM3, PP1 |